Arcus Biosciences, Inc. (RCUS)
23.12
-0.58
(-2.45%)
USD |
NYSE |
Apr 16, 11:34
Arcus Biosciences Research and Development Expense (Annual) : 523.00M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Gilead Sciences, Inc. | 5.688B |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Sarepta Therapeutics, Inc. | 1.493B |